Cite
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
MLA
Tim Crook, et al. “Epigenetic Silencing of Argininosuccinate Synthetase Confers Resistance to Platinum-Induced Cell Death but Collateral Sensitivity to Arginine Auxotrophy in Ovarian Cancer.” International Journal of Cancer, vol. 125, Sept. 2009, pp. 1454–63. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8625b231ffa628e81da92bd91a4af498&authtype=sso&custid=ns315887.
APA
Tim Crook, Christopher Kimberley, Dominique Koensgen, Louise Hiller, Peter Schmid, Linda J. Nicholson, Alexander Mustea, Paul R. Smith, Peter W. Szlosarek, & Jalid Sehouli. (2009). Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer. International Journal of Cancer, 125, 1454–1463.
Chicago
Tim Crook, Christopher Kimberley, Dominique Koensgen, Louise Hiller, Peter Schmid, Linda J. Nicholson, Alexander Mustea, Paul R. Smith, Peter W. Szlosarek, and Jalid Sehouli. 2009. “Epigenetic Silencing of Argininosuccinate Synthetase Confers Resistance to Platinum-Induced Cell Death but Collateral Sensitivity to Arginine Auxotrophy in Ovarian Cancer.” International Journal of Cancer 125 (September): 1454–63. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8625b231ffa628e81da92bd91a4af498&authtype=sso&custid=ns315887.